
    
      PRIMARY OBJECTIVE:

      I. To demonstrate the effectiveness of a clinical oncology pharmacist in the outpatient
      infusion center through education, and the identification and correction of medication
      related problem (MRP)s.

      SECONDARY OBJECTIVE:

      I. To evaluate overall patient and staff satisfaction with the added clinical oncology
      pharmacy education.

      EXPLORATORY OBJECTIVE:

      I. Estimate the cost avoidance utilizing the pharmacy services provided in the prospective
      trial.

      OUTLINE:

      PHASE I: Patients' medical records are reviewed.

      PHASE II: Patients receive pharmacist-led education on antineoplastic therapies including
      what to expect during infusion, general drug facts, common adverse effects, side effect
      management, and when to contact provider.

      After completion of study, patients are followed up periodically.
    
  